BRAF V600E mutation in papillary thyroid microcarcinoma: is it a predictor for the prognosis of patients with intermediate to high recurrence risk?

被引：0
作者：
Jingjia Cao
Baojin Chen
Xiaolu Zhu
Yaru Sun
Xiao Li
Wei Zhang
Ximing Wang
机构：
[1] the Second Hospital of Shandong University,Department of Nuclear Medicine
[2] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Radiology
[3] Shandong University,Department of Radiology, Shandong Provincial Hospital
来源：
Endocrine | 2024年 / 84卷
关键词：
Radioiodine therapy; BRAF; Papillary thyroid microcarcinoma; Therapy response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：160 / 170
页数：10
相关论文
共 122 条
[21]  
Doherty GM(2018)The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study Eur. J. Surg. Oncol. 44 1020-1031
[22]  
Mandel SJ(2017)Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC) J. Clin. Endocrinol. Metab. 102 679-687
[23]  
Nikiforov YE(2014)Surgery for neck recurrence of differentiated thyroid cancer: outcomes and risk factors World J. Surg. 38 undefined-undefined
[24]  
Xing M(undefined)BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients? undefined undefined undefined-undefined
[25]  
Westra WH(undefined)undefined undefined undefined undefined-undefined
[26]  
Tufano RP(undefined)undefined undefined undefined undefined-undefined
[27]  
Cohen Y(undefined)undefined undefined undefined undefined-undefined
[28]  
Rosenbaum E(undefined)undefined undefined undefined undefined-undefined
[29]  
Rhoden KJ(undefined)undefined undefined undefined undefined-undefined
[30]  
Chen Y(undefined)undefined undefined undefined undefined-undefined
12345678910